back to top
Home NHSJS Using C. elegans to model the effects of Cystic Fibrosis

Using C. elegans to model the effects of Cystic Fibrosis

0
3910

References

  1. Broicks, A., Janssen, H. W. R. M., Calafat, J., & Plasterk, R. H. A. (1995). A P-glycoprotein protects Caenorhabditis elegans against natural toxins. The EMBO Journal, 14(9), 1858-1866.
  2. CFTR. (2016, May 10). Retrieved May 10, 2016, from https://ghr.nlm.nih.gov/gene/CFTR
  3. CFTR Modulators. (n.d.). Retrieved April 14, 2017, from https://www.cff.org/Life-With-CF/Treatments-and-Therapies/CFTR-Modulator-Therapies/
  4. Cystic Fibrosis – Gene Mutations and CFTR protein. (n.d.). Retrieved April 05, 2017, from http://www.nchpeg.org/nutrition/index.php?option=com_content&view=article&id=462&Itemid=564&limitstart=4
  5. Diamant, S., Eliahu, N., Rosenthal, D., & Goloubinoff, P. (2001). Chemical Chaperones Regulate Molecular Chaperones in Vitro and in Cells under Combined Salt and Heat Stresses. Journal of Biological Chemistry, 276(43), 39586-39591. doi:10.1074/jbc.m103081200
  6. Dufficux, F., Annereau, J. P., Boucher, J., Miclet, E., Pamlard, O., Schneider, M., . . . Lallemand, J. Y. (2000, September). Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies. Retrieved April 14, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/10951189
  7. European Bioinformatics Institute Protein Information Resource SIB Swiss Institute of Bioinformatics. (2017, March 15). Multidrug resistance protein pgp-3. Retrieved April 05, 2017, from http://www.uniprot.org/uniprot/P34713
  8. Griffits, J., Huffman, D., Whitacre, J., & Barrows, B. (2003). Resistance to a Bacterial Toxin Is Mediated by Removal of a Conserved Glycosylation Pathway Required for Toxin-Host Interactions. The Journal of Biological Chemistry, 278(46), 45594-45602.
  9. He, L., Skirkanich, J., Moronetti, L., Lewis, R., & Lamitina, T. (2012). The cystic-fibrosis-associated ΔF508 mutation confers post-transcriptional destabilization on the C. elegans ABC transporter PGP-3. Disease Models & Mechanisms, 5(6), 930–939.
  10. Lodish, H., & Berk, A. (2012). Protein Folding. Molecular Cell Biology (70-77). New York, NY: Freeman.
  11. Lodish, H., & Berk, A. (2012). Protein Folding. Molecular Cell Biology (594-601). New York, NY: Freeman.
  12. Mahajan-Miklos, S., Tan, M., Rahme, L., & Ausubel, F. (1999). Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas aeruginosa– Caenorhabditis elegans Pathogenesis Model. Cell, 96(1), 47-56.
  13. Mayo Clinic Staff Print. (2016, October 13). Symptoms and causes. Retrieved April 05, 2017, from http://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/symptoms-causes/dxc-20211893
  14. Roth, D., Hutt, D., & Tong, J. (2014). Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding. PLOS, 12(11), 1-20.
  15. What is CF. (n.d.). Retrieved April 09, 2017, from https://www.esiason.org/what-is-cf/faqs
  16. Zhang, L., Yu, J., Xie, Y., Lin, H., Huang, Z., Xu, L., . . . Guan, X. (2014). Biological Activity of Bacillus thuringiensis (Bacillales: Bacillaceae) Chitinase Against Caenorhabditis elegans (Rhabditida: Rhabditidae). Journal of Economic Entomology, 107(2), 551-558. doi:10.1603/ec13201

LEAVE A REPLY

Please enter your comment!
Please enter your name here